UA27252C2 - Похідні піразоло[1,5-а]піридину, які є антагоністами аденозину, та спосіб їх отримання - Google Patents

Похідні піразоло[1,5-а]піридину, які є антагоністами аденозину, та спосіб їх отримання

Info

Publication number
UA27252C2
UA27252C2 UA93002532A UA93002532A UA27252C2 UA 27252 C2 UA27252 C2 UA 27252C2 UA 93002532 A UA93002532 A UA 93002532A UA 93002532 A UA93002532 A UA 93002532A UA 27252 C2 UA27252 C2 UA 27252C2
Authority
UA
Ukraine
Prior art keywords
adenozine
pyrazolo
antagonists
obtaining
pyridine derivatives
Prior art date
Application number
UA93002532A
Other languages
English (en)
Russian (ru)
Inventor
Єуіті Сіокава
Еуити Сиокава
Атсусі Акахане
Атсуси Акахане
Хірохіто Катаяма
Хирохито Катаяма
Такафумі Мітсунага
Такафуми Митсунага
Original Assignee
Фудзісава Фармасьютікал Ко, Лтд
Фудзисава Фармасьютикал Ко, ЛтД
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фудзісава Фармасьютікал Ко, Лтд, Фудзисава Фармасьютикал Ко, ЛтД filed Critical Фудзісава Фармасьютікал Ко, Лтд
Publication of UA27252C2 publication Critical patent/UA27252C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Developing Agents For Electrophotography (AREA)

Abstract

Даний винахід направлений на створення способів отримання нової сполуки піразолопіридину і його фармацевтично прийнятної солі. Він стосується і способу застосування споолуки піразолопіридину, який передбачає введення її людині або тваринам. Нова сполука піразолопіридину відповідно до даного винаходу може бути представлена такою формулою де R1 означає арил, R2 означає ацил(нижчий) алкіл і А означає нижчий алкенілен.
UA93002532A 1991-04-10 1993-06-18 Похідні піразоло[1,5-а]піридину, які є антагоністами аденозину, та спосіб їх отримання UA27252C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919107513A GB9107513D0 (en) 1991-04-10 1991-04-10 Pyrazolopyridine compound and processes for preparation thereof

Publications (1)

Publication Number Publication Date
UA27252C2 true UA27252C2 (uk) 2000-08-15

Family

ID=10692949

Family Applications (1)

Application Number Title Priority Date Filing Date
UA93002532A UA27252C2 (uk) 1991-04-10 1993-06-18 Похідні піразоло[1,5-а]піридину, які є антагоністами аденозину, та спосіб їх отримання

Country Status (23)

Country Link
US (1) US5234930A (uk)
EP (1) EP0516941B1 (uk)
JP (2) JP2546470B2 (uk)
KR (1) KR100248700B1 (uk)
CN (2) CN100508975C (uk)
AT (1) ATE146473T1 (uk)
AU (1) AU653007B2 (uk)
CA (1) CA2065644C (uk)
DE (1) DE69215965T2 (uk)
DK (1) DK0516941T3 (uk)
ES (1) ES2095976T3 (uk)
FI (1) FI100969B (uk)
GB (1) GB9107513D0 (uk)
GR (1) GR3022113T3 (uk)
HU (2) HU214871B (uk)
IE (1) IE921086A1 (uk)
IL (1) IL101544A (uk)
MX (1) MX9201672A (uk)
NO (1) NO300271B1 (uk)
RU (1) RU2069662C1 (uk)
SG (1) SG43917A1 (uk)
TW (1) TW205550B (uk)
UA (1) UA27252C2 (uk)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541213A (en) * 1993-06-24 1996-07-30 Eisai Co., Ltd. Propenoic acid derivatives diazole propenoic acid compounds which have useful pharmaceutical utility
AU694157B2 (en) * 1993-12-29 1998-07-16 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine adenosine antagonists
US6214843B1 (en) * 1996-04-25 2001-04-10 Fujitsawa Pharmaceutical Co., Ltd. Preventives and remedies for ischemic intestinal lesion and ileus
AUPO111096A0 (en) * 1996-07-18 1996-08-08 Fujisawa Pharmaceutical Co., Ltd. New compound
EP0972525A4 (en) * 1997-03-18 2000-11-29 Fujisawa Pharmaceutical Co PREVENTIVE AND HEALING AGENTS AGAINST HYPERPHOSPHATEMIA
EP1084710B1 (en) * 1998-06-01 2006-10-18 Astellas Pharma Inc. Adenosine a1 antagonists for male sterility
US20040152659A1 (en) * 1999-05-12 2004-08-05 Fujisawa Pharmaceutical Co. Ltd. Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist
PE20020506A1 (es) * 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
ES2243579T3 (es) * 2000-12-15 2005-12-01 Glaxo Group Ltd Derivados de pirazolopirideno.
DE60112609T2 (de) * 2000-12-15 2006-01-19 Glaxo Group Ltd., Greenford Pyrazolopyridine
ATE274515T1 (de) * 2001-03-08 2004-09-15 Smithkline Beecham Corp Pyrazolopyridinderivate
US7034030B2 (en) * 2001-03-30 2006-04-25 Smithkline Beecham Corporation Pyralopyridines, process for their preparation and use as therapeutic compounds
US20050107400A1 (en) * 2001-03-30 2005-05-19 Boyd Leslie F. Use of pyrazolopyridines as therapeutic compounds
WO2002083672A1 (en) * 2001-04-10 2002-10-24 Smithkline Beecham Corporation Antiviral pyrazolopyridine compounds
DE60204452T2 (de) * 2001-04-27 2005-12-15 Smithkline Beecham Corp. Pyrazolo[1,5a]Pyridinderivate
AUPR548601A0 (en) * 2001-06-06 2001-06-28 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyrazinecompound and pharmaceutical use thereof
EP1401836B1 (en) * 2001-06-21 2006-08-23 SmithKline Beecham Corporation Imidazo¬1,2-a|pyridine derivatives for the prophylaxis and treatment of herpes viral infections
JP2005507878A (ja) * 2001-09-07 2005-03-24 スミスクライン ビーチャム コーポレーション ヘルペス感染症を治療するためのピラゾロ−ピリジン類
DE60211539T2 (de) * 2001-10-05 2006-09-21 Smithkline Beecham Corp. Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion
DE60222465T2 (de) * 2001-12-11 2008-06-05 Smithkline Beecham Corp. Pyrazolopyridin-derivate als antiherpesmittel
WO2004033454A1 (en) * 2002-10-03 2004-04-22 Smithkline Beecham Corporation Therapeutic compounds based on pyrazolopyridine derivatives
AU2007258567B2 (en) * 2006-06-06 2012-04-19 Medicinova, Inc. Substituted pyrazolo (1,5-alpha) pyridine compounds and their methods of use
US9572528B1 (en) 2012-08-06 2017-02-21 Los Angeles Biomedical Research Insitute at Harbor-UCLA Medical Center Monitor for SIDS research and prevention

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925849A (en) * 1987-06-15 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutically useful pyrazolopyridines
GB8901423D0 (en) * 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof

Also Published As

Publication number Publication date
EP0516941A1 (en) 1992-12-09
NO921413D0 (no) 1992-04-09
KR100248700B1 (ko) 2000-08-01
TW205550B (uk) 1993-05-11
EP0516941B1 (en) 1996-12-18
HU214871B (hu) 1998-07-28
ES2095976T3 (es) 1997-03-01
AU653007B2 (en) 1994-09-15
DE69215965D1 (de) 1997-01-30
SG43917A1 (en) 1997-11-14
CN100508975C (zh) 2009-07-08
ATE146473T1 (de) 1997-01-15
GB9107513D0 (en) 1991-05-29
KR920019787A (ko) 1992-11-20
JP2546470B2 (ja) 1996-10-23
JPH05112566A (ja) 1993-05-07
NO300271B1 (no) 1997-05-05
RU2069662C1 (ru) 1996-11-27
HU211680A9 (en) 1995-12-28
HUT61300A (en) 1992-12-28
MX9201672A (es) 1992-10-01
FI100969B (fi) 1998-03-31
HU9201213D0 (en) 1992-07-28
IE921086A1 (en) 1992-10-21
US5234930A (en) 1993-08-10
CN1067427A (zh) 1992-12-30
CN1205205A (zh) 1999-01-20
GR3022113T3 (en) 1997-03-31
AU1398892A (en) 1992-10-15
FI921522A (fi) 1992-10-11
NO921413L (no) 1992-10-12
CN1041203C (zh) 1998-12-16
JPH08208650A (ja) 1996-08-13
IL101544A0 (en) 1992-12-30
IL101544A (en) 1996-06-18
JP2903040B2 (ja) 1999-06-07
FI921522A0 (fi) 1992-04-07
DE69215965T2 (de) 1997-04-10
DK0516941T3 (da) 1997-01-06
CA2065644C (en) 2002-12-03
CA2065644A1 (en) 1992-10-11

Similar Documents

Publication Publication Date Title
UA27252C2 (uk) Похідні піразоло[1,5-а]піридину, які є антагоністами аденозину, та спосіб їх отримання
UA32546C2 (uk) 1,2-заміщені 1н-імідазо[4,5-с]хінолін-4-аміни, проміжні сполуки для їх синтезу, антивірусна фармацевтична композиція, спосіб лікування інфікованих ссавців, спосіб індукування біосинтезу інтерферону у ссавців, спосіб уповільнення росту бластом
IE821515L (en) Imidazopyridines and imidazopyrazines
GR3033869T3 (en) IMIDAZO 4,5-c]QUINOLINE AMINES
DE3855575D1 (de) Wasserlösliche Camptothecin-Analoge
MY130755A (en) Colchinol derivatives as vascular damaging agents
ZA817297B (en) Imidazo(1,2-a)pyridine derivatives useful in therapy and their preparation
EP0430045A3 (en) Ascorbic acid tocopheryl phosphate diesters for inhibition of maillard's reaction
DE3671370D1 (de) Zubereitungen zur behandlung von mycoplasmosen und bakteriellen erkrankungen bei gefluegel.
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
IL92078A0 (en) Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
HUP9900438A2 (hu) Pirazolo[4,3-d]pirimidin-7-on-származékok alkalmazása gerincvelő-sérülés következtében fellépő impotencia kezelésére használható gyógyszerkészítmények előállítására
ES2007064A6 (es) Un procedimiento para la obtencion de 4(3h)-oxo-5,6,8-tetrahidropirido (2,3-d)pirimidinas
IL82574A (en) 2-((hetero) aryl)-n- (substituted alkyl)- imidazo (4,5-b) and -(4,5-c) pyridines, their preparation and pharmaceutical compositions containing them
JPS6479186A (en) Ester substituted thienotriazolodiazepine compound and medicinal use thereof
EP0314984A3 (de) Verwendung von 2-Pyrimidinyl-1-piperazin-Derivaten
ES8705439A1 (es) Procedimiento para preparar derivados de pirazol-(1,5-a)piridina
PT85866A (en) Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives
PT1025101E (pt) Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central
ES8304125A1 (es) "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina".
AU3126289A (en) 4,5,6,7-tetrahydro isothiazolo (4,5-c) pyridine derivatives
EP0115920A3 (en) Pyrazino(2',3'-3,4)pyrido(1,2-a) indole derivatives
DE3665593D1 (en) Peptide immunostimulants
DE69630876D1 (de) Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8
EP0292981A3 (en) 2-selenomethyl-1, 4-dihydropyridines a process for the preparation thereof and pharmaceutical compositions containing them